CBL and cancer: Shivanna and colleagues have shown that c-CBL ubiquitin ligase regulates nuclear β-catenin and angiogenesis by affecting its tyrosine phosphorylation via modulations in Wnt signaling, suggesting potential therapeutic benefit of targeting c-CBL in angiogenesis-associated diseases, including cancer [24, 25].